Antimicrobial stewardship & healthcare epidemiology : ASHE最新文献

{"title":"An outbreak after all: <i>Cutibacterium acnes</i> among pediatric patients with cerebrospinal fluid diversion device infections highlights gaps in guidelines.","authors":"Felicia Scaggs Huang, Cameron Griffin, Matthew Fenchel, Melanie DuBose, Andrea Ankrum, Joshua K Schaffzin","doi":"10.1017/ash.2024.359","DOIUrl":"https://doi.org/10.1017/ash.2024.359","url":null,"abstract":"<p><strong>Objective: </strong><i>Cutibacterium acnes</i> is normal skin flora but can cause sterile implant infections. We investigated a cluster of seven patients with <i>C. acnes</i> in anaerobic cerebrospinal fluid (CSF) cultures in November 2020. Further analysis identified a missed outbreak, highlighting ambiguity in diagnosis of indolent organisms in the 2017 IDSA meningitis guidelines.</p><p><strong>Design: </strong>Outbreak investigation.</p><p><strong>Setting: </strong>Quaternary pediatric facility.</p><p><strong>Patients: </strong>A case was defined as a hospitalized patient with <i>C. acnes</i> isolated from CSF culture from January 1, 2016 to December 31, 2022.</p><p><strong>Methods: </strong>We defined comparison periods based on timing of <i>C. acnes</i> culture positivity as 1) pre-outbreak (2016-2020), 2) outbreak (2020-2021), and 3) post-outbreak (2022). Rates of <i>C. acnes</i> positive cultures per 1000 CSF cultures and rate ratios were calculated by comparison periods.</p><p><strong>Results: </strong>We identified 9 positive <i>C. acnes</i> CSF cultures among 7 cases November 10-27, 2020, all with at least 1 CSF diversion device. The anaerobic culture media was substituted at the time of case cluster. In 2021, the culture media was implemented permanently with no increase in <i>C. acnes</i> culture positivity. The rate of <i>C. acnes</i> positive CSF cultures and rate ratio increased in the outbreak period (p=0.01) compared to pre-outbreak and post-outbreak periods. There was no difference between the pre- and post-outbreak periods.</p><p><strong>Conclusions: </strong>Retrospective analysis of CSF culture data led to reclassifying a <i>C. acnes</i> pseudo-outbreak as a true outbreak in CSF diversion devices at our institution. Clearer guidance is needed to delineate the role of <i>C. acnes</i> in CSF diversion device infections.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406564/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"CLABSIs aren't just for inpatients: the need to identify CLABSI burden among outpatients.","authors":"Opeyemi Oladapo-Shittu, Sara E Cosgrove, Clare Rock, Yea-Jen Hsu, Eili Klein, Anthony D Harris, Carlos Mejia Chew, Heather Saunders, Patrick R Ching, Avi Gadala, Stephanie Mayoryk, Lisa Pineles, Lisa L Maragakis, Alejandra B Salinas, Taylor Helsel, Sara C Keller","doi":"10.1017/ash.2024.384","DOIUrl":"https://doi.org/10.1017/ash.2024.384","url":null,"abstract":"","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406563/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Are C-reactive protein and procalcitonin safe and useful for antimicrobial stewardship purposes in patients with COVID-19? A scoping review.","authors":"Anita Williams, Ernestina Repetto, Ishmael Lebbie, Mohamad Khalife, Tomas Oestergaard Jensen","doi":"10.1017/ash.2024.372","DOIUrl":"https://doi.org/10.1017/ash.2024.372","url":null,"abstract":"<p><strong>Objective: </strong>The primary objectives of this study were to assess the usefulness of C-reactive protein (CRP) and procalcitonin (PCT) in the diagnosis of bacterial co-infections in coronavirus disease 2019 (COVID-19) and if their incorporation in antimicrobial stewardship (AMS) programs is safe and useful, stratified by severity of disease as level of care, intensive care unit (ICU) or non-ICU. Our secondary objectives were to identify cut-off values for antibiotic decision-making and identify reported results from low- and middle-income countries (LMICs).</p><p><strong>Design: </strong>A scoping review of published literature, adhering to the PRISMA statement for Systematic Reviews and Meta-analyses Extension for Scoping Reviews guidelines. The last search was performed in January 2024.</p><p><strong>Results: </strong>Fifty-nine studies were included in this scoping review: 20 studies reporting predictive values and/or sensitivity/specificity results for PCT, 8 reporting clear objectives on AMS, and 3 studies from LMICs.</p><p><strong>Conclusion: </strong>In the context of non-ICU hospitalized COVID-19 patients in high-income countries, a PCT value below 0.25 mg/L can be a useful tool to rule out bacterial co-infection. The wide range of reported negative predictive values suggests that PCT should be interpreted in the context of other clinical findings. Our results do not support the use of CRP in the same manner as PCT. There is a clear need for more studies in LMICs.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406566/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Real-world effectiveness of fidaxomicin in patients at high risk of <i>Clostridioides difficile</i> recurrence.","authors":"Benjamin Colwell, Jennifer Aguilar, Frances Hughes, Pavel Goriacko, Victor Chen, Mei Chang, Rachel Bartash, Yi Guo","doi":"10.1017/ash.2024.381","DOIUrl":"https://doi.org/10.1017/ash.2024.381","url":null,"abstract":"<p><strong>Objective: </strong>Compare the real-world impact of fidaxomicin (FDX) and vancomycin (VAN) on <i>Clostridioides difficile</i> infection (CDI) recurrence in a high-risk patient population.</p><p><strong>Design: </strong>A retrospective, matched-cohort study evaluating hospitalized patients with CDI from January 1, 2016, to November 1, 2022, within a tertiary academic medical center.</p><p><strong>Patients: </strong>Adult patients with at least 1 prior CDI case who received either FDX or VAN for non-fulminant CDI while admitted, and had at least 1 additional risk factor for recurrence. Risk factors included age >70, solid organ or bone marrow transplant recipients, broad-spectrum antibiotic use within 30 days, or receipt of chemotherapy/immune-modulating agents within 30 days of admission. FDX and VAN patients were matched according to risk factors.</p><p><strong>Results: </strong>A total of 415 patient admissions were identified. After the exclusion of 92 patients for fulminant CDI, diarrhea from another cause, or use of VAN taper therapy, and 15 unmatched patients, 308 patient admissions were included (68 FDX and 240 VAN patients). There were no significant differences in 4-week recurrence (26% vs 23%; OR 1.1; <i>P</i> = .51), 90-day CDI readmission (29% vs 23%; <i>P</i> = .65), or 90-day all-cause readmission (54% vs 53%; <i>P</i> = .91). There was a significant 17% decrease in 90-day mortality associated with the use of FDX (OR .3; <i>P</i> = .04).</p><p><strong>Conclusions: </strong>In a real-world high-risk patient population, the use of FDX compared to oral VAN did not result in decreased CDI recurrence within 4 weeks or fewer hospital readmissions within 90 days. Further research is needed to better assess the value of FDX in this patient population.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406562/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of methicillin-resistant <i>Staphylococcus aureus</i> nasal swab screening at a large comprehensive cancer center.","authors":"Mark J Herrington, Chun Feng, Hyunsoo Hwang, Nancy N Vuong","doi":"10.1017/ash.2024.370","DOIUrl":"https://doi.org/10.1017/ash.2024.370","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to determine the predictive values of MRSA swab screenings in patients with cancer.</p><p><strong>Methods: </strong>This is a retrospective cohort observational study of adult patients admitted to The University of Texas MD Anderson Cancer Center between January 2019 and October 2022. Data collected from patients with documented MRSA nasal swab screenings and clinical cultures taken within 7 days were collected. The first documented MRSA swab screening and culture results from unique patients were included for analysis to calculate sensitivity, specificity, positive predictive value, and NPV.</p><p><strong>Results: </strong>A total of 6475 patients with MRSA nasal swab cultures had 13129 clinical cultures from different anatomical sites. Of the patients included, 57% had a solid tumor and 37% had a hematological malignancy, with 82% of patients receiving an anti-MRSA antibiotic prior to MRSA nasal swab. There were 167 documented positive MRSA cultures, most commonly from a wound (41.3%) or respiratory source (24%). Overall sensitivity and specificity for all culture sites were 50.9% and 98.4%, respectively, with an overall NPV of 99.4%. The NPV was 99.8% for bloodstream infections, 98.5% for respiratory infections, 92.6% for wound infections, and greater than 99% for other culture sites.</p><p><strong>Conclusion: </strong>The specificity and negative predictive value of MRSA swab screenings in patients with cancer was high overall and consistent with the literature in immunocompetent patients. These results may aid in antimicrobial stewardship activities that can help guide the discontinuation of empiric antibiotics in patients with cancer.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Social and ecological determinants of antimicrobial resistance in Africa: a systematic review of epidemiological evidence.","authors":"Catherine Bennett, Will Russel, Rebecca Upton, Frank Frey, Bineyam Taye","doi":"10.1017/ash.2024.375","DOIUrl":"https://doi.org/10.1017/ash.2024.375","url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial resistance (AMR) is one of the greatest global health problems for humans, animals, and the environment. Although the association between various factors and AMR is being increasingly researched, the need to understand the contribution of social and ecological determinants, especially in developing nations, remains. This review fills these knowledge gaps by synthesizing existing evidence on the social and ecological determinants of AMR in Africa.</p><p><strong>Results: </strong>Twenty-four studies were selected based on predefined criteria from PubMed. 58.33% (n = 14) and 29.17% (n = 7) of the studies reported on ecological and social determinants of AMR, respectively, and 3 (12.5%) studies documented both social and environmental determinants of AMR. Sociodemographic factors include increased household size, poor knowledge, attitudes toward AMR, low educational levels, and rural residences. Indicators of poor water sanitation and hygiene, framing practices, and consumption of farm products were among the common ecological determinants of AMR and AM misuse in Africa.</p><p><strong>Conclusion: </strong>Our review demonstrates the importance of social and ecological determinants of AMR among African populations. The findings may be valuable to researchers, policymakers, clinicians, and those working in lower-income countries to implement AMR prevention programs utilizing a holistic approach.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11384158/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Situations predisposing primary care patients to use antibiotics without a prescription in the United States.","authors":"Lindsey A Laytner, Barbara W Trautner, Susan Nash, Fabrizia Faustinella, Roger Zoorob, Kiara Olmeda, Michael K Paasche-Orlow, Larissa Grigoryan","doi":"10.1017/ash.2024.361","DOIUrl":"https://doi.org/10.1017/ash.2024.361","url":null,"abstract":"<p><strong>Background: </strong>Patients' situations can impact their intentions to use antibiotics without medical guidance (non-prescription use) in the future. This survey determines the prevalence of intended (future) use of non-prescription antibiotics for 13 predefined situations and identifies the sociodemographic characteristics associated with intended use for these types of situations.</p><p><strong>Methods: </strong>Patient surveys (N = 564) were conducted from January 2020 to June 2021 in the waiting rooms of 6 safety-net primary care clinics and 2 emergency departments in a private healthcare system. We used principal component analysis to identify 3 situational summary factors: barriers to a doctor visit, accessibility of non-prescription antibiotics, and previous symptom relief with antibiotics. Multivariate linear regression identified the sociodemographic predictors associated with each summary factor.</p><p><strong>Results: </strong>The most common situations triggering patients to use non-prescription antibiotics were a perceived high cost of doctor visits (29.8%), having leftover prescription antibiotics (50.4%), and experiencing symptom relief with prior use of antibiotics (47.5%). Multivariate regression results revealed that younger patients (<i>P</i> < 0.04) and patients attending the safety-net health system (<i>P</i> < 0.001) had more intended use of non-prescription antibiotics for all 3 summary factors.</p><p><strong>Conclusions: </strong>Future stewardship interventions should consider the types of situations that drive patients' decisions to use antibiotics without a prescription. Interventions aimed at reducing barriers to health care (eg, high costs and long waits associated with doctor appointments) and educating individuals on medically appropriate, nonantibiotic treatment options may reduce antibiotic use and antimicrobial resistance.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11384165/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A novel approach for safe and automated implementation of far ultraviolet-C light decontamination in clinical areas.","authors":"Samir Memic, Jennifer L Cadnum, Andrew Osborne, William A Rutala, Curtis J Donskey","doi":"10.1017/ash.2024.388","DOIUrl":"https://doi.org/10.1017/ash.2024.388","url":null,"abstract":"<p><p>A novel wall-mounted far ultraviolet-C (UV-C) light technology providing automated delivery of far UV-C only when people are not present reduced methicillin-resistant <i>Staphylococcus aureus</i> in a patient room and equipment room. The safety feature that discontinues far UV-C output when people are detected was effective in preventing far UV-C exposure.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11384163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Procedural risk factors for deep and organ/space surgical site infection post-coronary artery bypass graft surgery.","authors":"Abarna Pearl, Patrick S Gordon, Baevin S Feeser, Dana E Pepe, Preeti Mehrotra, Sharon B Wright","doi":"10.1017/ash.2024.374","DOIUrl":"https://doi.org/10.1017/ash.2024.374","url":null,"abstract":"<p><p>In this study, we examined the impact of the number and type of arterial grafts, and surgical dressing type, on deep and organ/space surgical site infection following coronary artery bypass graft procedures. Bilateral internal mammary artery grafts and negative pressure wound therapy were associated with higher odds of infection.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11384151/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antibiotic utilization trends in Veterans Affairs patients with <i>Stenotrophomonas maltophilia</i> bloodstream infections.","authors":"Clara H Lee, Ursula C Patel, Amanda Vivo, Lishan Cao, Charlesnika T Evans","doi":"10.1017/ash.2024.364","DOIUrl":"https://doi.org/10.1017/ash.2024.364","url":null,"abstract":"<p><strong>Objective: </strong><i>Stenotrophomonas maltophilia</i> is a multidrug-resistant gram-negative bacillus that can cause serious infections but has limited treatment options. This study aims to establish trends in the treatment of <i>S. maltophilia</i> bloodstream infections (BSI) across the United States in Department of Veterans Affairs (VA) facilities.</p><p><strong>Methods: </strong>Data was evaluated over a 10-year timeframe (2012 to 2021) in this retrospective cohort study. Veterans with ≥ 1 blood culture with <i>S. maltophilia</i> within a VA medical encounter were included. Microbiology, pharmacy, and patient information were collected through national VA data sources and chart review. Descriptive statistics and Poisson regression were used to summarize patient demographics, facility characteristics, microbiologic data, and treatment trends.</p><p><strong>Results: </strong>A total of 374 blood cultures positive for <i>S. maltophilia</i> were identified across 75 VA facilities. Of 282 unique patients with BSI, the majority were male (93.6%), white (67.4%), with a mean age of 64 ± 13.1 years. Of those patients, 78% received treatment, 12.8% had a polymicrobial blood culture, and 5.3% had a documented sulfa allergy. Susceptibility results were most reported for trimethoprim-sulfamethoxazole (TMP-SMX), levofloxacin, and ceftazidime, with 4.5%, 4.3%, and 44.4% resistant isolates, respectively. Antibiotics most prescribed included TMP-SMX (41.5%) and levofloxacin (39.4%), followed by ciprofloxacin (13.8%) and ceftazidime (12.4%). Combination therapy was prescribed in 33% of patients. No significant trends were found with antibiotic utilization over time.</p><p><strong>Conclusions: </strong>TMP-SMX and levofloxacin were the most prescribed antibiotics for <i>S. maltophilia</i> BSI treatment. No significant changes were seen with antibiotic prescribing trends in Veterans from 2012 to 2021.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11384161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}